OrbiMed Capital GP VII LLC, Director, 10% Owner at Theseus Pharmaceuticals, Inc. (THRX), bought 80,934 shares at $9.43 ($796K) on 2022-01-13, disclosed to the SEC on 2022-01-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.81 | 1,600 | $16K | 2.0% |
| 2 | $10.67 | 6,900 | $74K | 9.2% |
| 3 | $10.06 | 18,897 | $190K | 23.9% |
| 4 | $10.06 | 18,897 | $190K | 23.9% |
| 5 | $9.43 | 17,320 | $163K | 20.5% |
| 6 | $9.43 | 17,320 |
| $163K |
| 20.5% |
| Total | $9.84 avg | 80,934 | $796K | 100% |
| Filing → |
| PASG | SELL | 2024-12-26 | $276K | — | Filing → |
| PASG | SELL | 2024-12-06 | $77K | — | Filing → |
| PASG | SELL | 2024-09-18 | $147K | — | Filing → |